Our Mission
The Inflammation Research Foundation was founded in 2003 as a non-profit 501 (c) (3) foundation dedicated to supporting basic and clinical research to develop innovative nutritional approaches that reprogram disrupted metabolic pathways, an underlying cause of many chronic diseases.
Leadership
Dr. Barry Sears-President
Dr. Barry Sears founded the Inflammation Research Foundation in 2003 to address the need for high-quality clinical research to understand the relationship between diet and metabolism. He has published more than 50 scientific articles, written 19 books on dietary control of metabolism, including the #1 New York Times bestseller The Zone. He has 14 US patents in the areas of drug delivery technology and dietary management of hormonal responses.
Dr. Asish Saha-Director of Research
Dr. Saha is one of the leading authorities in AMPK research. He was previously an Associate Professor at the Boston University School of Medicine and has more than 100 scientific publications on AMPK.
Mary Perry-Director of Clinical Trials
Mary serves as the Director of Clinical Trials for Inflammation Research Foundation and coordinates all clinical trials at the foundation.
Scientific Advisory Board
We make extensive use of our Scientific Advisory Board to provide insights on the latest breakthroughs in biotechnology from a diverse number of fields.
IRF Scientific Advisory Board
CHARLES SERHAN, PHD, HARVARD MEDICAL SCHOOL
Charles Serhan is one of the world’s leaders in eicosanoid biochemistry and discovered the role of resolvins in the resolution of inflammation. He is the Simon Gelman Professor of Anesthesia at the Harvard Medical School and director of the Center of Experimental Therapeutics and Reperfusion Injury at the Brigham and Women’s Hospital. In 2017, he received the International Eicosanoid Research Foundation’s Lifetime Achievement Award. He has authored more than 500 scientific publications, written five books, and has been awarded more than 200 patents.
CAMILLO RICORDI, MD, UNIVERSITY OF MIAMI MEDICAL SCHOOL
Camillo Ricordi is one of the world’s leaders in cell transplantation for the treatment of diabetes. He is the Stacy Joy Goodman Professor of Surgery, distinguished professor of medicine, professor of biomedical engineering, and microbiology and immunology, and serves as scientific director and chief academic officer of the University of Miami Diabetes Research Institute. In 2019 he was appointed as member of Italy’s Supreme Council of Health. He has authored more than 700 scientific publications and has been awarded 11 patents.
CAROL JOHNSTON, PHD, ARIZONA STATE UNIVERSITY
Carol Johnston is a professor of Nutrition at Arizona State University and director of the Nutrition Program. She is a leading expert in functional foods. She received the Grace Goldsmith Award for significant achievements in the field of nutrition by a scientist under the age of 50 years sponsored by the American College of Nutrition in 2004 and the Mark Bieber Professional Award sponsored by the American College of Nutrition for academic accomplishments in 2008. Her research areas include vitamin C and dietary interventions in obesity and diabetes. She has more than 100 scientific publications.
To Our Supporters
At the Inflammation Research Foundation, we are doing something that has never been done before, and we want you to become part of the story. Join us and help change the world.
The Inflammation Research Foundation (IRF) funds both basic and clinical research to demonstrate the ability of Metabolic Engineering to help reduce the rising economic burden of chronic disease.
The IRF is a Massachusetts nonprofit public benefit corporation (EIN 41-6518089) and a recognized entity that is tax-exempt under Section 501(c)(3) of the Internal Revenue Code since 2003. Online donations acknowledge that the donor has imposed no restrictions on IRF use of such gifted funds, and that IRF provided no goods or services in return for the donation.